Department of Obstetrics and Gynecology, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Seo-Gu Incheon Metropolitan City, Simgokro 100 Gil 25, Incheon, 22711, South Korea.
Surg Endosc. 2022 Oct;36(10):7114-7125. doi: 10.1007/s00464-022-09227-5. Epub 2022 Apr 25.
To evaluate the risks of symptomatic lymphocele after pelvic lymphadenectomy between the laparoscopic and abdominal approach in uterine cervical and endometrial cancer.
We searched Ovid Medline, Ovid EMBASE, and the Cochrane library through April 2020. We selected the comparative studies contained information on symptomatic lymphoceles in postoperative complications. All articles searched were independently reviewed and selected by two researchers. A meta-analysis was performed using the Stata MP version 16.0 software package.
A total of 33 eligible clinical trials were ultimately enrolled in this meta-analysis. When all studies were pooled, the odds ratios (OR) of the laparoscopic approach for the risk of symptomatic lymphoceles compared to the abdominal approach was 0.58 [95% confidence interval (CI): 0.42-0.81, p = 0.022, I-squared = 0.0%]. The risk of postoperative symptomatic lymphoceles in the laparoscopic group tended to decrease over time in the cumulative meta-analysis. In the subgroup analysis, there was no evidence for an association between cancer type, quality of the study methodology, hysterectomy type, and postoperative symptomatic lymphoceles. However, in a recently published article, being overweight (body mass index ≥ 25) and studies conducted in oriental area were associated with a lower incidence of postoperative symptomatic lymphoceles.
Laparoscopic lymphadenectomy was associated with a significantly lower risk of postoperative symptomatic lymphoceles than abdominal lymphadenectomy (PROSPERO registration number: CRD 42,020,187,165).
评估腹腔镜与开腹子宫颈癌和子宫内膜癌盆腔淋巴结清扫术后症状性淋巴囊肿的风险。
我们检索了 Ovid Medline、Ovid EMBASE 和 Cochrane 图书馆,检索时间截至 2020 年 4 月。我们选择了包含术后并发症症状性淋巴囊肿信息的比较研究。所有检索到的文章均由两名研究人员独立审查和选择。使用 Stata MP 版本 16.0 软件包进行荟萃分析。
共有 33 项符合条件的临床试验最终纳入本荟萃分析。当所有研究合并时,与开腹手术相比,腹腔镜手术发生症状性淋巴囊肿的风险的优势比(OR)为 0.58 [95%置信区间(CI):0.42-0.81,p=0.022,I-squared=0.0%]。在累积荟萃分析中,腹腔镜组术后症状性淋巴囊肿的风险随时间推移呈下降趋势。亚组分析表明,癌症类型、研究方法学质量、子宫切除术类型与术后症状性淋巴囊肿之间无关联。然而,在最近发表的一篇文章中,超重(体重指数≥25)和在东方地区进行的研究与术后症状性淋巴囊肿发生率降低相关。
与开腹淋巴结清扫术相比,腹腔镜淋巴结清扫术与术后症状性淋巴囊肿的发生风险显著降低(PROSPERO 注册号:CRD 42,020,187,165)。